Join a clinical study for a treatment for Eyebrow Hair Loss in Participants with Alopecia Areata, Alopecia Universalis and Alopecia Totalis
The purpose of this clinical research study is to evaluate the safety and effectiveness of an investigational medication applied to your eyebrow area for the treatment of eyebrow hair loss in participants with alopecia areata, alopecia universalis and alopecia totalis.
You may be qualified to participate if you:
- are at least 18 years old;
- have loss of eyebrow hair due to alopecia areata, alopecia universalis or alopecia totalis;
- have been experiencing eyebrow hair loss for at least 6 months and no more than 10 years;
- are willing to stop any current prohibited treatments for your eyebrow or scalp hair loss;
- are willing to attend to regular study visits (up to 11 visits, 2-4 weeks apart) involving lab tests, electrocardiograms, questionnaires, and other study procedures for the duration of the study (up to 28 weeks).
For participants, all investigational medication, study-related tests and study-related doctor’s visits will be provided at no cost for the duration of the study. Participation is voluntary, and you may withdraw at any time. Participants may be reimbursed for reasonable travel expenses for study visits.
This clinical trial is being conducted at two dermatology clinics in Australia.
- Sinclair Dermatology, East Melbourne
For more information, please contact:
Georgina Hollmann Ph: 0455 915 411
Email: georgina.hollmann@sinclairdermatology.com.au
- St George Dermatology & Skin Cancer Centre, Kogarah, Sydney
For more information, please contact:
Sharyn Hutchinson
Ph: (02) 9587 4277
Email: clinicaltrials@stgeorgedermatology.com.au